Where Is Wellbeing? Searching for the Physical Organisation Behind Cell-Free Therapy

Behind Wellbeing — Chapter One

Wellbeing International Foundation presents Cell-Free Therapy internationally, describes more than twenty years of research and says it works through a network spanning multiple continents. But what actually constitutes Wellbeing International Foundation as a physical organisation? Where are its clinics? Where are its scientists? Where is its laboratory? And when a patient says they have been “treated by Wellbeing,” who actually treated them?

For the last twelve chapters, I have investigated the people, companies, patents and investment proposition surrounding Wellbeing International Foundation.

But eventually I realised I had been asking the wrong question.

I had spent months asking:

Who is behind Wellbeing?

Perhaps the more fundamental question is:

Where is Wellbeing?

That sounds ridiculously simple.

For an organisation describing itself as working in biotechnology and regenerative medicine, you might expect the answer to be equally simple.

A headquarters.

A research centre.

A laboratory.

Clinical facilities.

Scientists.

Doctors.

Treatment rooms.

Research infrastructure.

Instead, Wellbeing's own current website describes something rather different.

It identifies:

a headquarters in Bermuda;

a GMP-certified laboratory in Germany;

and:

23 partner clinics across the United States, Europe, the Middle East, Africa and the Pacific. (Wellbeing International Foundation)

Notice the wording.

Partner clinics.

That distinction is where this new investigation begins.

First, an Important Correction

Before going further, there is one claim I will not make.

I will not say that Wellbeing has “no clinical trials.”

There is now a registered study.

Wellbeing's website identifies NCT07322224, and the study appears in the clinical-trial record as a completed interventional pilot concerning a multimodal longevity programme incorporating autologous cell-free conditioned media. (Wellbeing International Foundation)

The study began in August 2024 and was subsequently published in Frontiers in Aging in 2026.

Fourteen participants completed it.

It was open-label.

Single-arm.

There was no control or sham comparator.

And the intervention combined CFT-related conditioned media with lifestyle changes and nutritional supplementation. The published authors themselves say that larger controlled trials are required. (PubMed)

There is another important detail.

The trial record identifies BlueBird Age Reversal SA as the lead sponsor, with xLongevity and Wellbeing International Foundation as collaborators. (Clareo Health)

So Wellbeing does have a documented clinical-study connection.

But that discovery doesn't end our investigation.

It makes the next question more precise:

What clinical and research infrastructure actually exists behind Wellbeing itself?

What Does Wellbeing Say It Is?

Wellbeing's LinkedIn profile categorises the organisation as:

Biotechnology Research.

It describes it as privately held, founded in 2015, headquartered in Bermuda and employing somewhere within the 11–50 employee category. (LinkedIn)

Its own website presents something substantial.

Twenty-plus years of research.

More than fifteen years of clinical experience.

A German GMP laboratory.

An international clinical network.

Cell banking.

Physician partnerships.

Research.

A scientific team.

And Cell-Free Therapy being delivered internationally. (Wellbeing International Foundation)

Taken together, this creates the impression of a significant biotechnology operation.

So let's look for it.

Start With the Headquarters

Wellbeing identifies its headquarters as:

Hamilton, Bermuda.

Its older testimonial website provides a more specific address:

Williams House20 Reid StreetHamilton HM11Bermuda. (Wellbeing International Foundation)

Its LinkedIn profile also identifies Williams House as its primary location. (LinkedIn)

So we have an address.

But an address and an operational headquarters are not necessarily the same thing.

That distinction matters.

The questions we now need to answer are:

How much space does Wellbeing occupy there?

How many employees work there?

Is this where Andrew Chancellor works?

Is there scientific activity there?

Is there clinical activity?

Are patients seen there?

Is biological material handled there?

Is it primarily administrative?

Or is Williams House principally the registered or correspondence location for the organisation?

None of those possibilities is inherently problematic.

International companies routinely use serviced offices and registered-office providers.

But if we want to understand what Wellbeing actually is, we need to establish the difference between its legal address and its operational footprint.

Where Is the Wellbeing Clinic?

This was the next obvious question.

Wellbeing describes an international treatment operation.

So where are its clinics?

Its current website doesn't describe 23 Wellbeing-owned clinics.

It says:

“23 partner clinics.” (Wellbeing International Foundation)

That is materially different.

Wellbeing's treatment-process page says blood is collected at an:

“approved collection point.”

Samples are then transported to Germany.

And the resulting preparations are administered at:

“approved clinical locations”

by qualified medical professionals. (Wellbeing International Foundation)

Again, notice the terminology.

Not necessarily:

Wellbeing clinic.

Instead:

collection point.

partner clinic.

approved clinical location.

This suggests a distributed model rather than a conventional clinic network.

And there is nothing inherently wrong with that.

But it means we need to stop imagining Wellbeing as a traditional medical institution until we establish that it operates like one.

Perhaps Wellbeing Isn't Really a Clinic Operator

This may turn out to be the first important conclusion of this series.

Wellbeing may be better understood as an organisation sitting between several independent components.

Potentially:

patient acquisition;

clinical screening;

a biological-processing protocol;

an external or separately operated laboratory;

logistics;

independent physicians;

and partner clinics.

That would be a perfectly recognisable modern business model.

But it would be fundamentally different from an organisation owning and operating its own hospitals, clinics, laboratories and medical staff.

And that distinction matters enormously when evaluating both medical responsibility and investment value.

Wellbeing Is Actively Recruiting Other Doctors' Clinics

Its physician material makes this model clearer.

Wellbeing actively invites existing medical practitioners to join its network.

Its current physician programme contains three tiers.

Team physicians.

Academic and research physicians.

And:

“High-Volume PRP Practitioners.”

That third category is particularly revealing.

Wellbeing describes these as established regenerative practices and advertises:

“Clear revenue model and projections”

and:

“Marketing and patient acquisition support.” (Wellbeing International Foundation)

That doesn't sound like Wellbeing building 23 clinics.

It sounds more like Wellbeing building a network through clinics that already exist.

Again, that can be a legitimate and scalable commercial model.

But investors and patients should understand what it means.

So Who Actually Treats the Patient?

Suppose someone becomes a Wellbeing patient.

Who is medically responsible?

Wellbeing says infusions are administered at approved clinical locations by qualified medical professionals. (Wellbeing International Foundation)

Fine.

But who employs that professional?

Wellbeing?

The partner clinic?

A separate medical organisation?

Who holds the medical indemnity?

Who makes the final clinical decision?

Who records the treatment?

Who reports an adverse event?

Who owns the patient record?

Who follows up complications?

And if something goes wrong:

who is legally responsible for the patient's treatment?

These are not accusations.

They are fundamental questions about a distributed medical model.

Then There Is the Laboratory

This may become one of the most important parts of the entire investigation.

Wellbeing repeatedly refers to a:

GMP-certified laboratory in Germany.

Its contact page describes Germany simply as:

“State-of-the-art GMP-certified laboratory for cell-free preparation processing.” (Wellbeing International Foundation)

But something immediately stands out.

On that contact page, the Bermuda headquarters receives an organisational name and location.

The German laboratory description, in the material I reviewed, does not identify the laboratory by corporate name.

That doesn't establish anything improper.

But it gives us our next investigative target.

What is the laboratory called?

Who owns it?

Where exactly is it?

Which German authority supervises it?

What is the GMP certificate number?

What activities does that certificate cover?

Does Wellbeing own the facility?

Does it lease it?

Or does an independent laboratory process material under contract?

These should be answerable questions.

“GMP Certified” Needs Context

The term GMP carries weight.

It means Good Manufacturing Practice.

But a statement that a laboratory is “GMP certified” does not, by itself, tell us everything about what that facility is authorised or certified to manufacture.

Scope matters.

Product category matters.

Manufacturing activity matters.

Regulatory authority matters.

Certification dates matter.

So in a later chapter we are going to find the actual facility and examine the actual regulatory documentation.

Not the marketing description.

The certificate.

Twenty-Three Partner Clinics — Let's Find Them

Wellbeing now says it has:

23 partner clinics

across:

the United States;

Europe;

the Middle East;

Africa;

and the Pacific. (Wellbeing International Foundation)

Good.

Then this should be independently testable.

We need to identify all 23.

For every location, we should establish:

Who owns it?

Who operates it?

Which physician provides CFT?

Does the clinic itself advertise Wellbeing?

Does it describe itself as a Wellbeing clinic or simply as a partner?

How long has the relationship existed?

Does it provide treatment regularly?

Or is it simply an approved location where an infusion can take place?

There is a huge difference between:

23 clinics owned and operated by a biotechnology organisation

and:

23 independent clinics authorised to administer its product or protocol.

The number may be identical.

The business underneath it is not.

Then We Need to Understand the Staff

LinkedIn places Wellbeing in the 11–50 employee category. (LinkedIn)

That is self-reported platform information, not an audited employee count.

So who are those people?

Scientists?

Laboratory technicians?

Doctors?

Nurses?

Administrators?

Sales staff?

Consultants?

Independent contractors?

We already know Wellbeing publicly identifies Andrew Chancellor as CEO and Stephen Ray as a senior scientific figure.

But if this is a biotechnology research organisation operating internationally, we should be able to map the scientific and operational team with considerably greater precision.

That will be another chapter.

Now Consider the Clinical Research

This is where the picture becomes particularly interesting.

Wellbeing says its approach rests on approximately:

20+ years of research

and:

15+ years of clinical experience. (Wellbeing International Foundation)

Yet Wellbeing's current About page makes a surprisingly clear statement:

“The peer-reviewed pilot named above is the only clinical study we cite.” (Wellbeing International Foundation)

That is worth stopping on.

Twenty-plus years of research.

More than fifteen years of claimed clinical experience.

Yet the organisation itself currently identifies one clinical study in support of its treatment narrative.

That doesn't mean the previous work didn't happen.

It doesn't mean the claimed clinical experience is false.

But it means we need to understand what Wellbeing means when it uses words such as:

research

and:

clinical experience.

Treating Patients Is Not the Same as Conducting Clinical Trials

This distinction is absolutely essential.

A doctor may treat hundreds of patients over many years.

That creates clinical experience.

It does not automatically create controlled clinical evidence.

Likewise, collecting patient observations is not the same as running a prospective controlled trial.

Testimonials are not clinical trials.

Case studies are not clinical trials.

White papers are not clinical trials.

A research library containing papers written by other scientists is not a Wellbeing clinical trial programme.

Wellbeing itself now acknowledges this distinction by saying its testimonials and case studies are patient-reported accounts and “are not offered as evidence of efficacy.” (Wellbeing International Foundation)

That is an important clarification.

But it creates another question.

What evidence was generated during the preceding fifteen years of claimed clinical experience?

There Is Something Else Interesting About the Registered Study

The trial registration deserves a chapter of its own.

The public record identifies the study as:

NCT07322224.

It began:

5 August 2024.

The primary completion was:

15 December 2024.

Study completion is recorded as:

20 March 2025.

But the registry record says it was first submitted on:

5 December 2025

and first posted on:

7 January 2026. (Syfrah)

In other words, according to the registry information currently reproduced from ClinicalTrials.gov, registration occurred after the study had already been completed.

That doesn't invalidate the study.

But prospective registration and retrospective registration are not the same thing.

And it is something readers should know.

There is another detail.

The lead sponsor is listed as:

BlueBird Age Reversal SA.

Wellbeing International Foundation appears as a collaborator.

So even the one registered study currently cited by Wellbeing requires us to understand the relationship between several organisations. (Clareo Health)

That is exactly what this series will do.

The Study Location Raises Another Question

The registry material identifies one study location:

Wellbeing International FoundationLondon, United Kingdom. (TrialScreen)

That immediately gives us another physical location to investigate.

Where in London was the study actually conducted?

Was this a Wellbeing-owned clinical facility?

A partner clinic?

A rented medical facility?

A research site?

Who was the legal operator?

Who employed the principal investigator?

Where were participants actually examined?

Where was blood taken?

Where were the preparations administered?

Again:

Where was Wellbeing?

A Virtual Organisation Can Still Be a Real Organisation

This needs to be emphasised.

An organisation does not have to own enormous buildings to be legitimate.

Modern biotechnology companies outsource.

They use contract research organisations.

They use contract manufacturing organisations.

They collaborate with universities.

They licence technology.

They use partner hospitals.

They operate internationally with relatively small central teams.

Some highly valuable biotechnology businesses are deliberately asset-light.

So the investigation isn't:

“They don't own clinics, therefore something is wrong.”

That would be simplistic.

The real question is:

What does Wellbeing actually own, control and operate itself?

That distinction becomes extremely important when the same organisation is also raising private investment.

Because an Asset-Light Business Can Become an Asset-Light Investment

This is where the investigation will eventually reconnect with the investment series.

If Wellbeing does not own its clinics...

if it does not own the German laboratory...

if clinicians are independent...

if intellectual property is held elsewhere...

if scientific know-how depends substantially upon individual consultants...

then what assets actually sit inside the entity investors are financing?

We do not yet know that all of those premises are true.

That is precisely what we're going to establish.

But investors need the answer.

Because outsourcing can make a company efficient.

It can also mean the company owns considerably fewer hard assets than its public presence might suggest.

Compare That With a Fully Integrated Research Institution

Later in this series we are going to make this comparison properly.

Not rhetorically.

Document by document.

Take an established regenerative-medicine research institution.

You can often identify:

the research buildings;

laboratories;

clean rooms;

clinical-trial infrastructure;

named principal investigators;

manufacturing facilities;

registered trials;

published protocols;

institutional affiliations;

ethics structures;

and regulatory infrastructure.

That doesn't automatically make its experimental therapies successful.

And it doesn't mean every large institution is a good investment.

But it makes the organisation itself relatively easy to locate and understand.

We are going to apply exactly the same test to Wellbeing.

Build the Organisation From the Outside In

This series is therefore going to reconstruct Wellbeing piece by piece.

Not from its branding.

From independently verifiable components.

The Bermuda headquarters.

Find it.

The German GMP laboratory.

Identify it.

The 23 partner clinics.

Map them.

The physicians.

Identify who employs them.

The research programme.

Separate Wellbeing-generated research from external literature.

The clinical evidence.

Identify every registered study.

The intellectual property.

Establish ownership.

The investment vehicle.

Identify its assets.

Only then can we answer the question:

What is Wellbeing International Foundation actually made of?

Questions for Wellbeing International Foundation

As always, there is a straightforward way for Wellbeing to answer much of this investigation.

We would welcome answers to the following.

What is the complete legal identity and registration number of Wellbeing International Foundation?

How many full-time employees does the organisation currently employ?

How many are scientists or medical professionals?

Does Wellbeing own or lease dedicated office space at Williams House in Bermuda?

Does Wellbeing own any clinical facilities anywhere in the world?

Which of the 23 locations described as partner clinics are independently owned?

Can Wellbeing provide the names and addresses of all 23?

What is the legal name and address of the German GMP laboratory?

Does Wellbeing own that laboratory?

Which authority issued its GMP certification and what activities does the certification cover?

Where exactly was NCT07322224 conducted in London?

Why was the study first registered publicly after the recorded completion date?

What Wellbeing-sponsored or Wellbeing-collaborative clinical studies preceded it?

And what clinical research records exist from the fifteen-plus years of clinical experience Wellbeing says underpin CFT?

None of those questions presupposes wrongdoing.

They simply locate the organisation.

What We Have Established — and What We Haven't

We have established that Wellbeing publicly identifies Bermuda as its headquarters. (Wellbeing International Foundation)

We have established that it describes a GMP-certified laboratory in Germany. (Wellbeing International Foundation)

We have established that it describes its delivery network as 23 partner clinics, rather than saying it owns 23 clinics. (Wellbeing International Foundation)

We have established that its process uses approved collection points and approved clinical locations. (Wellbeing International Foundation)

We have established that it actively recruits existing practitioners into its physician network. (Wellbeing International Foundation)

And we have established that there is now a registered clinical study connected with Wellbeing—but that Wellbeing was a collaborator rather than the listed lead sponsor, and the public registry record was posted after the recorded study completion. (Clareo Health)

We have not established that Wellbeing is merely a virtual company.

We have not established that the German laboratory is improperly described.

We have not established that its partner clinics lack appropriate licences.

We have not established that Wellbeing has misrepresented its employee numbers.

And we have not established that its distributed operating model is improper.

Those are precisely the things that now need investigating.

Conclusion: Where Is Wellbeing?

After all of this, the question remains surprisingly difficult to answer in conventional terms.

There is a Bermuda headquarters address.

There is a German laboratory described but not named on the contact page we reviewed.

There are 23 partner clinics.

There are approved collection points.

There are approved infusion locations.

There is a physician-partnership programme.

There is one clinical study currently cited by Wellbeing, registered under a different organisation as lead sponsor.

There is a scientific team.

And somewhere between all of those components sits:

Wellbeing International Foundation.

Perhaps that is simply what the organisation is.

Not a conventional clinic.

Not a hospital.

Not necessarily a vertically integrated biotechnology company.

But a distributed organisation connecting science, biological processing, clinicians, partner facilities and patients.

If so, there is nothing inherently wrong with that model.

But investors and patients deserve to understand it accurately.

Because the size of a network is not the same thing as the size of a company.

Access to a laboratory is not necessarily ownership of a laboratory.

Partner clinics are not necessarily company clinics.

Clinical experience is not the same thing as clinical trials.

And a headquarters address is not necessarily an operational headquarters.

So before we investigate what Wellbeing might someday become, we're going to establish something much simpler.

What physically exists today?

And we're starting with the place where Wellbeing says the science happens.

Next: Chapter Two — Inside the German Laboratory: Who Actually Makes Cell-Free Therapy?

Wellbeing repeatedly describes its German facility as a state-of-the-art GMP-certified laboratory. In Chapter Two, we go looking for it. Who owns the laboratory? Where is it? Which regulator certified it? What exactly does its GMP authorisation cover? Who works there? And does Wellbeing actually own the facility—or is the most important physical component of Cell-Free Therapy provided by somebody else?